/Investor DB

Horizons Ventures — 2020 Investments

4 investments dated 2020 · listed companies and verified rows first · show all

Certncertn.coin𝕏Series A · Nov 2020 · $21M

Certn provides background screening and identity verification software for HR and talent acquisition teams, offering criminal record checks, credit and civil litigation checks, professional register verifications, and reference checks across multiple countries.

AI & Machine LearningCybersecurityGovTechHR TechSaaS

Andrew McLeod(Founder)inOwen Madrick(Founder)in

Co-investorsInovia CapitalAngel Collective Opportunity FundB Capital GroupB4 CapitalBDC Growth Venture FundCyber Mentor Fund+13 more

Impossible Foodsimpossiblefoods.comin𝕏Mar 2020

Impossible Foods produces plant-based meat alternatives, including beef, pork, chicken, and sausage products designed to replicate the taste, nutrition, and cooking properties of conventional animal meat.

ConsumerFoodTechHealthtechRedwood City, US

Pat Brown(Founder)inDavid Lee(Executive Officer)inPeter McGuinnessinPatrick O. Brown(Founder)in

BoardBart Swanson(Director)inSamir Kaul(Director)in

Co-investors1435 CapitalAliya Capital PartnersAllied Venture PartnersAngelDAOBlue Horizon CorporationBVP Investors+33 more

MioTechmiotech.comin𝕏Nov 2020

MioTech provides ESG and carbon emissions data, digital solutions for corporate ESG, supply chain, portfolio and green finance management, and climate analytics, alongside sustainability and carbon advisory services.

Climate TechData & InfrastructureFintech

Jason Tu(Founder)in

Co-investorsB Capital GroupB4 CapitalJ.P. Morgan Asset ManagementReach CapitalZhenFund

Thumbnail for Surrozensurrozen.cominJun 2020 · $50M

Surrozen develops multifunctional biologic therapies that selectively activate Wnt signaling to address ophthalmic diseases with unmet medical needs.

BiotechHealthtechMedical DevicesSouth San Francisco, US

Anna Berkenblit(Director)Harold Varmus(Director)

BoardDavid Goeddel(Director)inCraig Parker(Executive Officer, Director)Tim Kutzkey(Director)in

Co-investors5AM VenturesAccess BiotechnologyThe Column Group

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.